Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C

This study has been completed.
Sponsor:
Collaborators:
Information provided by (Responsible Party):
Roy Hawke, PharmD, PhD, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT01018615
First received: November 20, 2009
Last updated: November 5, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)